Medizintechnik

Tentamus establishes TentaStart for medical device start-up companies

The presentation of the processes around the Medical Device Regulation (MDR), which will now become valid on 26 May 2021 after a one-year postponement, is complex and not always transparent, especially for young market participants (company founders, university start-ups or spin-offs, small manufacturers).

The TentaStart model of the Tentamus Group is specifically tailored for this target group and is now complemented by the great professional expertise as well as many years of market experience of TentaConsult in the field of medical devices. "Just in time to help these clients to overcome the often great disorientation of small companies in a legal framework that is already extremely complex due to the transition from the MDD (Medical Device Directive) to the MDR, we have decided to offer the service already established in other product areas for medical devices at very short notice," explains Ralf Sibbing, Managing Partner of TentaConsult Pharma & Med, which specialises in consulting and services for healthcare products in the Tentamus Group.

"We know that the application of the new Regulation (EU) 2017/745 is a particularly big headache for many young market participants. So, we want to make the start of cooperation with us particularly rewarding and, above all, uncomplicated with a full-service offer – precisely supported by the accredited laboratories of the Tentamus Group – and an attractive introductory price for this target group," Anja Heinrich of TentaConsult explains further.

In the first year of cooperation, TentaStart grants a 10 % discount on all prices for consulting and services as well as the analyses of the Tentamus laboratories. An individual initial consultation on the principles of conformity assessment and first placing on the market is of course included for start-ups.

Contact our expert for TentaStart on medical devices. We look forward to helping you

Über die Tentamus Group GmbH

Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China, Japan, India and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrosciences, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 70 locations worldwide. More than 3,000 highly-trained staff members work in over 3 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.

Firmenkontakt und Herausgeber der Meldung:

Tentamus Group GmbH
An der Industriebahn 26
13088 Berlin
Telefon: +49 (30) 206038-230
Telefax: +49 (30) 206038-190
http://www.tentamus.com

Ansprechpartner:
Anja Heinrich
Senior Consultant Medical Devices bei TentaConsult
Telefon: +49 251 928 715 62
E-Mail: anja.heinrich@tentaconsult.com
Für die oben stehende Story ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel